journal article·2017-01-11

Cancer Cell Specific Delivery of Photosystem I Through Integrin Targeted Liposome Shows Significant Anticancer Activity

Abhijit Saha, Saswat Mohapatra, Gaurav Das, Batakrishna Jana, Subhajit Ghosh, Debmalya Bhunia, Surajit Ghosh

Publisher page

Abstract

Many anticancer drugs are developed for the treatment of cancer from natural sources. Photosystem I (PSI), a protein complex present in the chloroplast, is involved in photosynthesis and generates reactive oxygen species (ROS) in plant. Here, we used the ROS generation property of PSI for cancer therapy. We show that PSI can enter into different kinds of cancer cell like human lung carcinoma (A549) and mouse melanoma (B16F10) cell lines and generate ROS inside the cells. It inhibits the proliferation of cancer cell and causes apoptotic death of cancer cells. We also show that PSI induces apoptosis through mitochondria-dependent internal pathway, induces caspase3, causes DNA fragmentation, and arrests cell cycle at SubG0 phase. We also prepared, using C 16 -LDV lipopeptide [C16 long chain attached on the N-terminal of the tripeptide containing amino acids leucine (L), aspartic acid (D), and valine (V) abbreviated as NH 2 -LDV-COOH], α 4 β 1 integrin targeted liposomal formulation of PSI, which specifically kills the cancer cell without affecting normal cells, and it is found to be more potent compared to clinically used drug doxorubicin. Finally, we found that LDV liposomal formulation of PSI inhibits the growth of tumor in C57BL/6J mice model.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photosynthetic Processes and Mechanisms · Mitochondrial Function and Pathology · ATP Synthase and ATPases Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Organic & Medicinal Chemistry Division and ‡Academy of Scientific and Innovative Research, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, West Bengal, India

Funding

Indian Council of Medical Research · Council of Scientific and Industrial Research · University Grants Commission · Department of Science and Technology, Ministry of Science and Technology

References (36)

Show source-provided references
1. 10.1038/nature0568710.1038/nature05687 ↗
2. 10.1104/pp.125.4.200710.1104/pp.125.4.2007 ↗
3. 10.1038/cr.2008.8610.1038/cr.2008.86 ↗
4. 10.1089/scd.2011.070910.1089/scd.2011.0709 ↗
5. 10.4161/cbt.7.3.545710.4161/cbt.7.3.5457 ↗
6. 10.1016/j.biopha.2014.03.01810.1016/j.biopha.2014.03.018 ↗
7. 10.1155/2014/10767110.1155/2014/107671 ↗
8. 10.1021/np200906s10.1021/np200906s ↗
9. 10.1016/j.jep.2005.05.01110.1016/j.jep.2005.05.011 ↗
10. 10.1016/0022-1759(91)90248-E10.1016/0022-1759(91)90248-E ↗
11. 10.1139/o90-19710.1139/o90-197 ↗
12. 10.1016/j.jep.2012.05.03010.1016/j.jep.2012.05.030 ↗
13. 10.2174/13895570978816759210.2174/138955709788167592 ↗
14. 10.1021/np030096l10.1021/np030096l ↗
15. 10.1007/s12094-007-0138-910.1007/s12094-007-0138-9 ↗
16. 10.1002/adma.20050029510.1002/adma.200500295 ↗
17. 10.1021/jp800586w10.1021/jp800586w ↗
18. 10.1038/nnano.2012.16510.1038/nnano.2012.165 ↗
19. 10.1039/c3cp53089b10.1039/c3cp53089b ↗
20. 10.1016/S0167-5729(99)00002-310.1016/S0167-5729(99)00002-3 ↗
21. 10.1016/S0009-2614(99)00543-610.1016/S0009-2614(99)00543-6 ↗
22. 10.1021/bi060330h10.1021/bi060330h ↗
23. 10.1016/j.bbabio.2004.03.01210.1016/j.bbabio.2004.03.012 ↗
24. 10.1016/j.bbabio.2010.10.01110.1016/j.bbabio.2010.10.011 ↗
25. 10.1016/j.cbpa.2014.12.00810.1016/j.cbpa.2014.12.008 ↗
26. 10.1104/pp.65.5.81410.1104/pp.65.5.814 ↗
27. 10.1371/journal.pbio.003023010.1371/journal.pbio.0030230 ↗
28. 10.1104/pp.125.4.200710.1104/pp.125.4.2007 ↗
29. 10.1021/np400517g10.1021/np400517g ↗
30. 10.1002/mc.1011810.1002/mc.10118 ↗
31. 10.1038/sj.cr.729004910.1038/sj.cr.7290049 ↗
32. 10.1016/j.canlet.2003.10.03110.1016/j.canlet.2003.10.031 ↗
33. 10.1007/s11095-009-9971-610.1007/s11095-009-9971-6 ↗
34. 10.1039/C6RA23864E10.1039/C6RA23864E ↗
35. 10.1016/j.jbiotec.2010.01.01210.1016/j.jbiotec.2010.01.012 ↗
36. 10.18632/oncotarget.185410.18632/oncotarget.1854 ↗